Does USTEKINUMAB Cause Onychomadesis? 424 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 424 reports of Onychomadesis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.5% of all adverse event reports for USTEKINUMAB.
424
Reports of Onychomadesis with USTEKINUMAB
0.5%
of all USTEKINUMAB reports
359
Deaths
378
Hospitalizations
How Dangerous Is Onychomadesis From USTEKINUMAB?
Of the 424 reports, 359 (84.7%) resulted in death, 378 (89.2%) required hospitalization, and 323 (76.2%) were considered life-threatening.
Is Onychomadesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 424 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Onychomadesis?
ADALIMUMAB (797)
METHOTREXATE (785)
RITUXIMAB (722)
TOCILIZUMAB (721)
ABATACEPT (703)
INFLIXIMAB (682)
SECUKINUMAB (678)
LEFLUNOMIDE (667)
GOLIMUMAB (660)
HYDROXYCHLOROQUINE (660)
Which USTEKINUMAB Alternatives Have Lower Onychomadesis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE